Abstract
Microbiomes live in symbiosis with their hosts at all stages of their life cycles, forming holobionts. The gut microbiome contributes to absorbing energy and affects the immune system and provides intense chemical communication and coordination of host physiological functions, characterizing the gut-brain axis. The human lifestyle promotes alterations in ecological relationships between the host and microbiome, as the non-rational use of antibiotics, biocides, and processed food, decreasing microbiome diversity and affecting gut homeostasis. This dysbiosis leads to disease development, as colitis, obesity, metabolic syndromes, diabetes mellitus, cancer, and liver, cardiovascular, and neurodegenerative diseases. Probiotic bacterial strains have been used in different dairy products to modulate the structure of the intestinal microbiome and recover a part of the lost functional balance, but a deep scientifical background is necessary to shift the focus of this product consumption, from food to pharmaceutical industry. Next-generation probiotic species have been sought with preventive and therapeutic characteristics; the main concern is efficiency and safety, which is the reason for the new category of live biotherapeutic products need to be standardized as drugs to be commercially viable, to search for intestinal homeostasis recovery and reducing dysbiosis and a chain of adverse effects that could culminate in severe and chronic diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
K. Aagaard, J. Ma, K.M. Antony, R. Ganu, J. Petrosino, J. Versalovic, The placenta harbors a unique microbiome. Sci. Transl. Med. 21, 237–265 (2014). https://doi.org/10.1126/scitranslmed.3008599
Abbas AK, Lichtman AH, Pillai S, Imunologia celular e molecular. (Elsevier, Rio de Janeiro, 2019)
A. Adak, M.R. Khan, An insight into gut microbiota and its functionalities. Cell. Mol. Life Sci. 76, 473–493 (2019). https://doi.org/10.1007/s00018-018-2943-4
R. Aerts, O. Honnay, A.V. Nieuwenhuyse, Biodiversity and human health: Mechanisms and evidence of the positive health effects of diversity in nature and green spaces. Br. Med. Bull. 127, 5–22 (2018). https://doi.org/10.1093/bmb/ldy021
A. Ait-Belgnaoui, W. Han, F. Lamine, H. Eutamene, J. Fioramonti, L. Bueno, V. Theodorou, Lactobacillus farciminis treatment suppresses stress-induced visceral hypersensitivity: A possible action through interaction with epithelial cells cytoskeleton contraction. Gut 55, 1090–1094 (2006). https://doi.org/10.1136/gut.2005.084194
C. Alcon-Giner, M.J. Dalby, S. Caim, J. Ketskemety, A. Shaw, K. Sim, M.A.E. Lawson, R. Kiu, C. Leclaire, L. Chalklen, M. Kujawska, S. Mitra, F. Fardus-Reid, G. Belteki, K. McColl, J.S. Kroll, P. Clarke, L.J. Hall, Microbiota supplementation with Bifidobacterium and Lactobacillus modifies the preterm infant gut microbiota and metabolome: An observational study. Cell Rep. Med. 1, 1–15 (2020). https://doi.org/10.1016/j.xcrm.2020.100077
C.V. Almeida, M.R. Camargo, E. Russo, A. Amedei, Role of diet and gut microbiota on colorectal cancer immunomodulation. World J. Gastroenterol. 25(2), 151–162 (2019). https://doi.org/10.3748/wjg.v25.i2.151
A. Almeida, A.L. Mitchell, M. Boland, S.C. Forster, G.B. Gloor, A. Tarkowska, T.D. Lawley, R.D. Finn, A new genomic blueprint of the human gut microbiota. Nature 568, 499–504 (2019). https://doi.org/10.1038/s41586-019-0965-1
A. Alok, I.D. Singh, S. Singh, M. Kishore, P.C. Jha, M.A. Iqubal, Probiotics: A new era of biotherapy. Adv. Biomed. Res. 6, 31 (2017). https://doi.org/10.4103/2277-9175.192625
K.R. Amato, M.C. Arrieta, M.B. Azad, C.W. Kuzawa, The human gut microbiome and health inequities. Proc Natl Acad Sci U S A 118, e2017947118 (2021). https://doi.org/10.1073/pnas.2017947118
A.N. Ardissone, D.M. Cruz, A.G. Davis-Richardson, K.T. Rechigl, N. Li, J.C. Drew, R. Murgas-Torrazza, R. Sharma, M.L. Hudak, E.W. Triplett, J. Neu, Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One 9, 1–8 (2014). https://doi.org/10.1371/journal.pone.0090784
A. Banik, S.K. Halder, C. Ghosh, K.C. Mondal, Fungal probiotics: Opportunity, challenge, and prospects, in Recent Advancement in White Biotechnology Through Fungi. Fungal Biology, ed. by A. Yadav, S. Singh, S. Mishra, A. Gupta, (Springer, Cham, 2019), pp. 101–117. https://doi.org/10.1007/978-3-030-14846-1_3
G. Berg, D. Rybakova, D. Fischer, et al., Microbiome definition re-visited: Old concepts and new challenges. Microbiome 8, 103 (2020). https://doi.org/10.1186/S40168-020-00875-0
P. Brinker, M.C. Fontaine, L.W. Beukeboom, J. Falcao Salles, Host, symbionts, and the microbiome: The missing tripartite interaction. Trends Microbiol. 27, 480–488 (2019). https://doi.org/10.1016/j.tim.2019.02.002
J.L. Brito Alves, Y. de Oliveira, N.N.C. Carvalho, R.G.S. Cavalcante, M.M. Pereira Lira, L.C.P.D. Nascimento, M. Magnani, H. Vidal, V.A. Braga, E.L. de Souza, Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions. Pharmacol. Res. 145, 104252 (2019). https://doi.org/10.1016/j.phrs.2019.104252
J. Cai, Z. Chen, W. Wu, Q. Lin, Y. Liang, High animal protein diet and gut microbiota in human health. Crit. Rev. Food Sci. Nutr., 1–13 (2021). https://doi.org/10.1080/10408398.2021.1898336
P.D. Cani, W.M. de Vos, Next-generation beneficial microbes: The case of Akkermansia muciniphila. Front. Microbiol. 8, 1765 (2017). https://doi.org/10.3389/fmicb.2017.01765
I. Castigliuolo, M.F. Riegler, L. Valenick, J.T. LaMont, C. Pothoulakis, Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 67, 302–307 (1999). https://doi.org/10.1128/IAI.67.1.302-307.1999
T. Cerdó, A. Ruiz, I. Acuña, et al., Gut microbial functional maturation and succession during human early life. Environ. Micobiol. 20, 2160–2177 (2018). https://doi.org/10.1111/1462-2920.14235
A. Chavira, P. Belda-Ferre, T. Kosciolek, F. Ali, P.C. Dorrestein, R. Knight, The microbiome and its potential for pharmacology. Handb. Exp. Pharmacol. 260, 301–326 (2019). https://doi.org/10.1007/164_2019_317
P. Chen, X. Tang, Gut microbiota as regulators of Th17/Treg balance in patients with myasthenia gravis. Front. Immunol. 12, 1–12 (2021). https://doi.org/10.3389/fimmu.2021.803101
H. Chung The, S.H. Le, Dynamic of the human gut microbiome under infectious diarrhea. Curr. Opin. Microbiol. 66, 79–85 (2022). https://doi.org/10.1016/j.mib.2022.01.006
O.O. Coker, W.K.K. Wu, S.H. Wong, J.J. Sung, J. Yu, Altered gut archaea composition and interaction with bacteria are associated with colorectal cancer. Gastroenterology 159, 1459–1470 (2020). https://doi.org/10.1053/j.gastro.2020.06.042
M.C. Collado, S. Rautava, J. Aakko, et al., Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep. 61(6), 1–13 (2016). https://doi.org/10.1038/srep23129
V. Coman, D.C. Vodnar, Gut microbiota and old age: Modulating factors and interventions for healthy longevity. Exp. Gerontol. 141, 111095 (2020). https://doi.org/10.1016/J.EXGER.2020.111095
A.V. Contreras, B. Cocom-Chan, G. Hernandez-Montes, T. Portillo-Bobadilla, O. Resendis-Antonio, Host-microbiome interaction and cancer: Potential application in precision medicine. Front. Physiol. 7, 606 (2016). https://doi.org/10.3389/fphys.2016.00606
A.Y. Coqueiro, R. Raizel, A. Bonvini, J. Tirapegui, M.M. Rogero, Probiotics for inflammatory bowel diseases: A promising adjuvant treatment. Int. J. Food Sci. Nutr. 70(1), 20–29 (2019). https://doi.org/10.1080/09637486.2018.1477123
M. Cordaillat-Simmons, A. Rouanet, B. Pot, Live biotherapeutic products: The importance of a defined regulatory framework. Exp. Mol. Med. 52(9), 1397–1406 (2020). https://doi.org/10.1038/s12276-020-0437-6
P.D. Cotter, C. Hill, R.P. Ross, Bacteriocins: Developing innate immunity for food. Nat. Rev. Microbiol. 3, 777–788 (2005). https://doi.org/10.1038/nrmicro1273
F. Cristofori, F. Indrio, V.L. Miniello, M. De Angelis, R. Francavilla, Probiotics in celiac disease. Nutrients 10(12), 1824 (2018). https://doi.org/10.3390/nu10121824
K. D’hoe, S. Vet, K. Faust, F. Moens, G. Falony, D. Gonze, V. Lloréns-Rico, L. Gelens, J. Danckaert, L. De Vuyst, J. Raes, Integrated culturing, modeling and transcriptomics uncovers complex interactions and emergent behavior in a three-species synthetic gut community. elife 7, e37090 (2018). https://doi.org/10.7554/eLife.37090.001
E.B.M. Daliri, F.K. Ofosu, R. Chelliah, B.H. Lee, D.H. Oh, Health impact and therapeutic manipulation of the gut microbiome. High Throughput 9, 17 (2020). https://doi.org/10.3390/ht9030017
E.B.M. Daliri, F.K. Ofosu, R. Chelliah, B.H. Lee, D.H. Oh, Challenges and perspective in integrated multi-omics in gut microbiota studies. Biomol. Ther. 11, 300 (2021). https://doi.org/10.3390/biom11020300
U. Daniluk, J. Daniluk, R. Kucharski, T. Kowalczyk, K. Pietrowska, P. Samczuk, A. Filimoniuk, A. Kretowski, D. Lebensztejn, M. Ciborowski, Untargeted metabolomics and inflammatory markers profiling in children with crohn’s disease and ulcerative colitis-A preliminary study. Inflamm. Bowel Dis. 25, 1120–1128 (2019). https://doi.org/10.1093/ibd/izy402
C. Dausset, S. Patrier, P. Gajer, C. Thoral, Y. Lenglet, J.M. Cardot, P. Judlin, J. Ravel, A. Nivoliez, Comparative phase I randomized open-label pilot clinical trial of Gynophilus® (Lcr regenerans®) immediate release capsules versus slow release muco-adhesive tablets. Eur. J. Clin. Microbiol. Infect. Dis. 37(10), 1869–1880 (2018). https://doi.org/10.1007/s10096-018-3321-8
C. Depommier, A. Everard, C. Druart, H. Plovier, M. Van Hul, S. Vieira-Silva, G. Falony, J. Raes, D. Maiter, N.M. Delzenne, M. de Barsy, A. Loumaye, M.P. Hermans, J.P. Thissen, W.M. de Vos, P.D. Cani, Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nat. Med. 25(7), 1096–1103 (2019). https://doi.org/10.1038/s41591-019-0495-2
M. Derrien, A.-S. Alvarez, W.M. de Vos, The gut microbiota in the first decade of life. Trends Microbiol. 27, 997–1010 (2019). https://doi.org/10.1016/J.TIM.2019.08.001
M.G. Dominguez-Bello, F. Godoy-Vitorino, R. Knight, M.J. Blaser, Role of the microbiome in human development. Gut 68, 1108 (2019). https://doi.org/10.1136/GUTJNL-2018-317503
C. Duvallet, S.M. Gibbons, T. Gurry, R.A. Irizarry, E.J. Alm, Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat. Commun. 8, 1–10 (2017). https://doi.org/10.1038/s41467-017-01973-8
K. Fadhlaoui, M.E. Arnal, M. Martineau, P. Camponova, B. Ollivier, P.W. O’Toole, J.F. Brugère, Archaea, specific genetic traits, and development of improved bacterial live biotherapeutic products: Another face of next-generation probiotics. Appl. Microbiol. Biotechnol. 104(11), 4705–4716 (2020). https://doi.org/10.1007/s00253-020-10599-8
FAO, IFAD, UNICEF, WFP, WHO, The State of Food Security and Nutrition in the World 2019. Safeguarding Against Economic Slowdowns and Downturns (FAO, Rome, 2019). Licence: CC BY-NC-SA 3.0 IGO
O. Fiehn, Metabolomics – The link between genotypes and phenotypes, in Functional Genomics, ed. by C. Town, (Springer, Dordrecht, 2002), pp. 155–171. https://doi.org/10.1007/978-94-010-0448-0_11
L. Flandroy, T. Poutahidis, G. Berg, G. Clarke, M. Dao, E. Decaestecker, E. Furman, T. Haahtela, S. Massart, H. Plovier, Y. Sanz, G. Rook, The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci. Total Environ. 627, 1018–1038 (2018). https://doi.org/10.1016/j.scitotenv.2018.01.288
W. Fong, Q. Li, J. Yu, Gut microbiota modulation: A novel strategy for prevention and treatment of colorectal cancer. Oncogene 39(26), 4925–4943 (2020). https://doi.org/10.1038/s41388-020-1341-1
R. Francavilla, M. Piccolo, A. Francavilla, L. Polimeno, F. Semeraro, F. Cristofori, S. Castellaneta, M. Barone, F. Indrio, M. Gobbetti, M. De Angelis, Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent IBS-type symptoms: A randomized, double-blind, placebo-controlled, multicenter trial. J. Clin. Gastroenterol. 53(3), e117–e125 (2019). https://doi.org/10.1097/MCG.0000000000001023
R. Fuller, Probiotics in man and animals. J. Appl. Bacteriol. 66, 365–378 (1989)
V.T. George, M.M. Varghese, M.S. Vaseem, A. Thomas, P.G. Ittycheria, C.K. Sreejith, The promising future of probiotics: A new era in periodontal therapy. J. Int. Oral Health 8, 404 (2016). https://doi.org/10.2047/jioh-08-03-21
C. Gil-Cruz, C. Perez-Shibayama, A.D. Martin, F. Ronchi, K. van der Borght, R. Niederer, L. Onder, M. Lütge, M. Novkovic, V. Nindl, G. Ramos, M. Arnoldini, E.M.C. Slack, V. Boivin-Jahns, R. Jahns, M. Wyss, C. Mooser, B.N. Lambrecht, M.T. Maeder, H. Rickli, L. Flatz, U. Eriksson, M.B. Geuking, K.D. McCoy, B. Ludewig, Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science 366, 881–886 (2019). https://doi.org/10.1126/science.aav3487
V. Gopalakrishnan, C.N. Spencer, L. Nezi, A. Reuben, M.C. Andrews, T.V. Karpinets, P.A. Prieto, D. Vicente, K. Hoffman, S.C. Wei, A.P. Cogdill, L. Zhao, C.W. Hudgens, D.S. Hutchinson, T. Manzo, M.M. de Petraccia, T. Cotechini, T. Kumar, W.S. Chen, S.M. Reddy, R.S. Sloane, J. Galloway-Pena, H. Jiang, P.L. Chen, E.J. Shpall, K. Rezvani, V.B. Jensen, A.G. Swennes, F. McAllister, E.M.R. Sanchez, Y. Zhang, E. Le Chatelier, L. Zitvogel, N. Pons, J.L. Austin-Breneman, L.E. Haydu, E.M. Burton, J.M. Gardner, E. Sirmans, J. Hu, A.J. Lazar, T. Tsujikawa, A. Diab, H. Tawbi, I.C. Glitza, W.J. Hwu, S.P. Patel, S.E. Woodman, R.N. Armaria, M.A. Davies, J.E. Gershenwald, P. Hwu, J.E. Lee, J. Zhang, L.M. Coussens, Z.A. Cooper, P.A. Futreal, C.R. Daniel, N.J. Ajami, J.F. Petrosino, M.T. Tetzlaff, P. Sharma, J.P. Alisson, R.R. Jenq, J.A. Wargo, Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97–103 (2018). https://doi.org/10.1126/science.aan4236
F. Graziani, A. Pujol, C. Nicoletti, S. Dou, M. Maresca, T. Giardina, M. Fons, J. Perrier, Ruminococcus gnavus E1 modulates mucin expression and intestinal glycosylation. J. Appl. Microbiol. 120, 1403–1417 (2016). https://doi.org/10.1111/jam.13095
A.C. Gregory, O. Zablocki, A.A. Zayed, A. Howell, B. Bolduc, M.B. Sullivan, The gut virome database reveals age-dependent patterns of virome diversity in the human gut. Cell Host Microbe 28, 724–740 (2020). https://doi.org/10.1016/j.chom.2020.08.003
A. Gupta, I.M. Reizman, C.R. Reisch, K.L. Prather, Dynamic regulation of metabolic flux in engineered bacteria using a pathway-independent quorum-sensing circuit. Nat. Biotechnol. 35(3), 273–279 (2017). https://doi.org/10.1038/nbt.3796
R. Hansen, I.R. Sanderson, R. Muhammed, S. Allen, C. Tzivinikos, P. Henderson, L. Gervais, I.B. Jeffery, D.P. Mullins, E.A. O’Herlihy, J.D. Weinberg, G. Kitson, R.K. Russell, D.C. Wilson, A double-blind, placebo-controlled trial to assess safety and tolerability of (Thetanix) Bacteroides thetaiotaomicron in adolescent Crohn’s disease. Clin. Transl. Gastroenterol. 12(1), e00287 (2020). https://doi.org/10.14309/ctg.0000000000000287
M.K. Heavey, D. Durmusoglu, N. Crook, A.C. Anselmo, Discovery and delivery strategies for engineered live biotherapeutic products. Trends Biotechnol. 1, S0167-7799(21)00176-1 (2021). https://doi.org/10.1016/j.tibtech.2021.08.002
A. Heintz-Buschart, P. Wilmes, Human gut microbiome: Function matters. Trends Microbiol. 26, 563–574 (2018). https://doi.org/10.1016/J.TIM.2017.11.002
P. Herd, A. Palloni, F. Rey, J.B. Dowd, Social and population health science approaches to understand the human microbiome. Nat. Hum. Behav. 2, 808–815 (2018). https://doi.org/10.1038/s41562-018-0452-y
M. Jabczyk, J. Nowak, B. Hudzik, B. Zubelewicz-Szkodzińska, Diet, probiotics and their impact on the gut microbiota during the COVID-19 pandemic. Nutrients 13(9), 3172 (2021). https://doi.org/10.3390/nu13093172
H.E. Jakobsson, T.R. Abrahamsson, M.C. Jenmalm, K. Harris, C. Quince, C. Jernberg, B. Björkstén, L. Engstrand, A.F. Andersson, Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 63, 559–566 (2014). https://doi.org/10.1136/gutjnl-2012-303249
J. Jiang, B. Yang, R.P. Ross, C. Stanton, J. Zhao, H. Zhang, W. Chen, Comparative genomics of Pediococcus pentosaceus isolated from different niches reveals genetic diversity in carbohydrate metabolism and immune system. Front. Microbiol. 11, 253 (2020). https://doi.org/10.3389/fmicb.2020.00253
A. Joly, F. Leulier, F. De Vadder, Microbial modulation of the development and physiology of the enteric nervous system. Trends Microbiol. 29, 686–699 (2021). https://doi.org/10.1016/j.tim.2020.11.007
M. Kamada, S. Hase, K. Sato, A. Toyoda, A. Fujiyama, Y. Sakakibara, Whole genome complete resequencing of Bacillus subtilis natto by combining long reads with high-quality short reads. PLoS One 9, e109999 (2014). https://doi.org/10.1371/journal.pone.0109999
T. Kamiya, L. Wang, P. Forsythe, G. Goettsche, Y. Mao, Y. Wang, G. Tougas, J. Bienenstock, Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55, 191–196 (2006). https://doi.org/10.1136/gut.2005.070987
E.R. Kim, H.N. Kwon, H. Nam, J.J. Kim, S. Park, Y.H. Kim, Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer. Sci. Rep. 9, 4786–4796 (2019). https://doi.org/10.1038/s41598-019-41216-y
E.Y. Klein, T.P. Van Boeckel, E.M. Martinez, R. Laxminarayan, Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A 115, E3463–E3470 (2018). https://doi.org/10.1073/pnas.1717295115
R. Knight, A. Vrbanac, B.C. Taylor, A. Aksenov, C. Callewaert, J. Debelius, A. Gonzalez, T. Kosciolek, L.I. McCall, D. McDonald, A.V. Melnik, J.T. Morton, J. Navas, R.A. Quinn, J.G. Sanders, A.D. Swafford, L.R. Thompson, A. Tripathi, Z.Z. Xu, J.R. Zaneveld, Q. Zhu, J.G. Caporaso, P.C. Dorrestein, Best practices for analysing microbiomes. Nat. Rev. Microbiol. 16, 410–422 (2018). https://doi.org/10.1038/s41579-018-0029-9
A.A. Kolodziejczyk, D. Zheng, E. Elinav, Diet–microbiota interactions and personalized nutrition. Nat. Rev. Microbiol. 17, 742–753 (2019). https://doi.org/10.1038/s41579-019-0256-8
K. Korpela, A. Salonen, B. Hickman, C. Kunz, N. Sprenger, K. Kukkonen, E. Savilahti, M. Kuitunen, W.M. Vos, Fucosylated oligosaccharides in mother’s milk alleviate the effects of caesarean birth on infant gut microbiota. Sci. Rep. 8, 1–7 (2017). https://doi.org/10.1038/s41598-018-32037-6
K.A. Krautkramer, J. Fan, F. Bäckhed, Gut microbial metabolites as multi-kingdom intermediates. Nat. Rev. Microbiol. 19(2), 77–94 (2021). https://doi.org/10.1038/s41579-020-0438-4
P. Kundu, E. Blacher, E. Elinav, S. Pettersson, Our gut microbiome: The evolving inner self. Cell 171, 1481–1493 (2017). https://doi.org/10.1016/J.CELL.2017.11.024
A.J. La Reau, G. Suen, The Ruminococci: Key symbionts of the gut ecosystem. J. Microbiol. 56, 199–208 (2018). https://doi.org/10.1007/s12275-018-8024-4
E. Lamousé-Smith, D. Kelly, I. De Cremoux, Designing bugs as drugs: Exploiting the gut microbiome. Am. J. Physiol. Gastrointest. Liver Physiol. 320, G295–G303 (2020). https://doi.org/10.1152/ajpgi.00381.2019
S.H. Lee, Y. Yun, S.J. Kim, E.J. Lee, Y. Chang, S. Ryu, H. Shin, H.L. Kim, H.N. Kim, J.H. Lee, Association between cigarette smoking status and composition of gut microbiota: Population-based cross-sectional study. J. Clin. Med. 7, 282 (2018). https://doi.org/10.3390/jcm7090282
T. Legesse Bedada, T.K. Feto, K.S. Awoke, A.D. Garedew, F.T. Yifat, D.J. Birri, Probiotics for cancer alternative prevention and treatment. Biomed. Pharmacother. 129, 110409 (2020). https://doi.org/10.1016/j.biopha.2020.110409
L.C. Lew, S.B. Choi, B.Y. Khoo, S. Sreenivasan, K.L. Ong, M.T. Liong, Lactobacillus plantarum DR7 reduces cholesterol via phosphorylation of AMPK that down-regulated the mRNA expression of HMG-CoA reductase. Korean J. Food Sci. Anim. Resour. 38(2), 350–361 (2018). https://doi.org/10.5851/kosfa.2018.38.2.350
M. Li, J. Wen, Recent progress in the application of omics technologies in the study of bio-mining microorganisms from extreme environments. Microb. Cell Fact. 20, 178 (2021). https://doi.org/10.1186/s12934-021-01671-7
E.C. Lindsay, N.B. Metcalfe, M.S. Llewellyn, The potential role of the gut microbiota in shaping host energetics and metabolic rate. J. Anim. Ecol. 89, 2415–2426 (2020). https://doi.org/10.1111/1365-2656.13327
P. Littlejohn, B.B. Finlay, When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition. BMC Med. 19(1), 31 (2021). https://doi.org/10.1186/s12916-021-01910-z
X. Liu, B. Mao, J. Gu, J. Wu, S. Cui, G. Wang, J. Zhao, H. Zhang, W. Chen, Blautia—A new functional genus with potential probiotic properties? Gut Microbes 13, 1875796 (2021). https://doi.org/10.1080/19490976.2021.1875796
S. Long, Y. Yang, C. Shen, Y. Wang, A. Deng, Q. Qin, L. Qiao, Metaproteomics characterizes human gut microbiome function in colorectal cancer. npj Biofilms Microbiomes 6, 14–24 (2020). https://doi.org/10.1038/s41522-020-0123-4
C. Long-Smith, K.J. O’Riordan, G. Clarke, C. Stanton, T.G. Dinan, J.F. Cryan, Microbiota-gut-brain axis: New therapeutic opportunities. Annu. Rev. Pharmacol. Toxicol. 60, 477–502 (2020). https://doi.org/10.1146/annurev-pharmtox-010919-023628
A.C. Luissint, C.A. Parkos, A. Nusrat, Inflammation and the intestinal barrier: Leukocyte–epithelial cell interactions, cell junction remodeling, and mucosal repair. Gastroenterology 151, 616–632 (2016). https://doi.org/10.1053/j.gastro.2016.07.008
P. Markowiak, K. Śliżewska, Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9), 1021 (2017). https://doi.org/10.3390/nu9091021
P.I. Megat Mohd Azlan, S.F. Chin, T.Y. Low, H.M. Neoh, R. Jamal, Analyzing the Secretome of gut microbiota as the next strategy for early detection of colorectal cancer. Proteomics 19(10), e1800176 (2019). https://doi.org/10.1002/pmic.201800176
A. Mejía-Caballero, V.A. Salas-Villagrán, A. Jiménez-Serna, A. Farrés, Challenges in the production and use of probiotics as therapeuticals in cancer treatment or prevention. J. Ind. Microbiol. Biotechnol. 48(9–10), kuab052 (2021). https://doi.org/10.1093/jimb/kuab052
C. Milani, S. Duranti, F. Bottacini, E. Casey, F. Turroni, J. Mahony, C. Belzer, S.D. Palacio, S.A. Montes, L. Mancabelli, G.A. Lugli, J.M. Rodriguez, L. Bode, W. de Vos, M. Gueimonde, A. Margolles, D. van Sinderen, M. Ventura, The first microbial colonizers of the human gut: Composition, activities, and health implications of the infant gut microbiota. Microbiol. Mol. Biol. Rev. 81, 1–67 (2017). https://doi.org/10.1128/MMBR00036-17
G.E. Miller, P.A. Engen, P.M. Gillevet, M. Shaikh, M. Sikaroodi, C.B. Forsyth, E. Mutlu, A. Keshavarzian, Lower neighborhood socioeconomic status associated with reduced diversity of the colonic microbiota in healthy adults. PLoS One 11, e0148952 (2016). https://doi.org/10.1371/journal.pone.0148952
J. Mishra, M. Stubbs, L. Kuang, N. Vara, P. Kumar, N. Kumar, Inflammatory bowel disease therapeutics: A focus on probiotic engineering. Mediat. Inflamm. 2022, 1–15 (2022). https://doi.org/10.1155/2022/9621668
J.A. Molina-Tijeras, J. Gálvez, M.E. Rodríguez-Cabezas, The immunomodulatory properties of extracellular vesicles derived from probiotics: A novel approach for the management of gastrointestinal diseases. Nutrients 11(5), 1038 (2019). https://doi.org/10.3390/nu11051038
M. Moreno-Paz, M.J. Gómez, A. Arcas, V. Parro, Environmental transcriptome analysis reveals physiological differences between biofilm and planktonic modes of life of the iron oxidizing bacteria Leptospirillum spp. in their natural microbial community. BMC Genom. 11, 404 (2010). https://doi.org/10.1186/1471-2164-11-404
M.E.F. Nader-Macías, P.R. De Gregorio, J.A. Silva, Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract. Pharmacol. Res. Perspect. 9(5), e00787 (2021). https://doi.org/10.1002/prp2.787
R. Nagpal, B.J. Neth, S. Wang, S.P. Mishra, S. Craft, H. Yadav, Gut mycobiome and its interaction with diet, gut bacteria and Alzheimer’s disease markers in subjects with mild cognitive impairment: A pilot study. EBioMedicine 59, 102950 (2020). https://doi.org/10.1016/j.ebiom.2020.102950
K. Nishida, D. Sawada, Y. Kuwano, H. Tanaka, K. Rokutan, Health benefits of Lactobacillus gasseri CP2305 tablets in young adults exposed to chronic stress: A randomized, double-blind, placebo-controlled study. Nutrients 11(8), 1859 (2019). https://doi.org/10.3390/nu11081859
M.P. O’Donnell, B.W. Fox, P.H. Chao, F.C. Schroeder, P. Sengupta, A neurotransmitter produced by gut bacteria modulates host sensory behaviour. Nature 583(7816), 415–420 (2020). https://doi.org/10.1038/s41586-020-2395-5
A. Oka, R.B. Sartor, Microbial-based and microbial-targeted therapies for inflammatory bowel diseases. Dig. Dis. Sci. 65(3), 757–788 (2020). https://doi.org/10.1007/s10620-020-06090-z
B. Olas, Probiotics, prebiotics and synbiotics-A promising strategy in prevention and treatment of cardiovascular diseases? Int. J. Mol. Sci. 21(24), 9737 (2020). https://doi.org/10.3390/ijms21249737
A. Oniszczuk, T. Oniszczuk, M. Gancarz, J. Szymańska, Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases. Molecules 26(4), 1172 (2021). https://doi.org/10.3390/molecules26041172
B. Peng, H. Li, X.X. Peng, Functional metabolomics: From biomarker discovery to metabolome reprogramming. Protein Cell 6, 628–637 (2015). https://doi.org/10.1007/s13238-015-0185-x
J. Plaza-Díaz, F.J. Ruiz-Ojeda, L.M. Vilchez-Padial, A. Gil, Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients 9(6), 555 (2017). https://doi.org/10.3390/nu9060555
E.L. Plummer, D.M. Bulach, G.L. Murray, S.E. Jacobs, S.N. Tabrizi, S.M. Garland, ProPrems Study Group, Gut microbiota of preterm infants supplemented with probiotics: Sub-study of the ProPrems trial. BMC Microbiol. 18, 1–8 (2018). https://doi.org/10.1186/s12866-018-1326-1
B. Pot, Y. Vandenplas, Factors that influence clinical efficacy of live biotherapeutic products. Eur. J. Med. Res. 26(1), 40 (2021). https://doi.org/10.1186/s40001-021-00509-7
M. Primec, M. Klemenak, D. Di Gioia, I. Aloisio, N. Bozzi Cionci, A. Quagliariello, M. Gorenjak, D. Mičetić-Turk, T. Langerholc, Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids. Clin. Nutr. 38(3), 1373–1381 (2019). https://doi.org/10.1016/j.clnu.2018.06.931
E.M. Quigley, The efficacy of probiotics in IBS. J. Clin. Gastroenterol. 42, S85–S90 (2008). https://doi.org/10.1097/MCG.0b013e31816244ca
S. Rampelli, S. Turroni, C. Mallol, C. Hernandez, B. Galván, A. Sistiaga, E. Biagi, A. Astolfi, P. Brigidi, S. Benazzi, C.M. Lewis Jr., C. Warinner, C.A. Hofman, S.L. Schnorr, M. Candela, Components of a Neanderthal gut microbiome recovered from fecal sediments from El Salt. Commun. Biol. 4 (2021). https://doi.org/10.1038/s42003-021-01689-y
A. Ray, A. Khare, N. Krishnamoorthy, Z. Qi, P. Ray, Regulatory T cells in many flavors control asthma. Mucosal Immunol. 3, 216–229 (2010). https://doi.org/10.1038/mi.2010.4
G. Reid, R. Kort, S. Alvarez, R. Bourdet-Sicard, V. Benoit, M. Cunningham, D.M. Saulnier, J.E.T. van Hylckama Vlieg, H. Verstraelen, W. Sybesma, Expanding the reach of probiotics through social enterprises. Benef. Microbes 9(5), 707–715 (2018). https://doi.org/10.3920/BM2018.0015. Wageningen Academic Publishers
M.A.M. Rogers, M.T. Greene, S. Saint, C.E. Chenoweth, P.N. Malani, I. Trivedi, D.M. Aronoff, Higher rates of Clostridium difficile infection among smokers. PLoS One 7, e42091 (2012). https://doi.org/10.1371/journal.pone.0042091
G.A.W. Rook, 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Darwinian medicine and the ‘hygiene’ or ‘old friends’ hypothesis. Clin. Exp. Immunol. 160, 70–79 (2010). https://doi.org/10.1111/j.1365-2249.2010.04133.x
G.A.W. Rook, C.L. Raison, C.A. Lowry, Microbiota, immunoregulatory old friends and psychiatric disorders, in Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease, ed. by M. Lyte, J.F. Cryan, (Springer, New York, 2014), pp. 319–356
A. Rouanet, S. Bolca, A. Bru, I. Claes, H. Cvejic, H. Girgis, A. Harper, S.N. Lavergne, S. Mathys, M. Pane, B. Pot, C. Shortt, W. Alkema, C. Bezulowsky, S. Blanquet-Diot, C. Chassard, S.P. Claus, B. Hadida, C. Hemmingsen, C. Jeune, B. Lindman, G. Midzi, L. Mogna, C. Movitz, N. Nasir, M. Oberreither, J.F.M.L. Seegers, L. Sterkman, A. Valo, F. Vieville, M. Cordaillat-Simmons, Live Biotherapeutic Products, a road map for safety assessment. Front. Med. (Lausanne) 7, 237 (2020). https://doi.org/10.3389/fmed.2020.00237
C. Rousseaux, X. Thuru, A. Gelot, N. Barnich, C. Neut, L. Dubuquoy, C. Dubuquoy, E. Merour, K. Geboes, M. Chamaillard, A. Ouwehand, G. Leyer, D. Carcano, J.F. Colombel, D. Ardid, P. Desreumaux, Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 13, 35–37 (2007). https://doi.org/10.1038/nm1521
L. Rueda-Ruzafa, F. Cruz, P. Roman, D. Cardona, Gut microbiota and neurological effects of glyphosate. Neurotoxicology 75, 1–8 (2019). https://doi.org/10.1016/j.neuro.2019.08.006
E. Rutayisire, K. Huang, Y. Liu, F. Tao, The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: A systematic review. BMC Gastroenterol. 16, 1–12 (2016). https://doi.org/10.1186/s12876-016-0498-0
A. Rutsch, J.B. Kantsjö, F. Ronchi, The gut-brain axis: How microbiota and host inflammasome influence brain physiology and pathology. Front. Immunol. 11, 1–24 (2020). https://doi.org/10.3389/fimmu.2020.604179
R. Satokari, Modulation of gut microbiota for health by current and next-generation probiotics. Nutrients 11(8), 1921 (2019). https://doi.org/10.3390/nu11081921
B. Shan, Z. Ai, S. Zeng, Y. Song, J. Song, Q. Zeng, Z. Liao, T. Wang, C. Huang, D. Su, Gut microbiome-derived lactate promotes to anxiety-like behaviors through GPR81 receptor-mediated lipid metabolism pathway. Psychoneuroendocrinology 117, 104699 (2020). https://doi.org/10.1016/j.psyneuen.2020.104699
F. Shanahan, T.S. Ghosh, P.W. O’Toole, The healthy microbiome—What is the definition of a healthy gut microbiome? Gastroenterology 160, 483–494 (2021). https://doi.org/10.1053/j.gastro.2020.09.057
M. Shapira, Gut microbiotas and host evolution: Scaling up symbiosis. Trends Ecol. Evol. 31, 539–549 (2016). https://doi.org/10.1016/J.TREE.2016.03.006
A. Sharma, S.-H. In, Special issue on the human microbiome: From symbiosis to therapy. Exp. Mol. Med. 52, 1361 (2020). https://doi.org/10.1038/S12276-020-00488-5
C.C. Silva, M.A. Monteil, E.M. Davis, Overweight and obesity in children are associated with an abundance of Firmicutes and reduction of Bifidobacterium in their gastrointestinal microbiota. Child. Obes. 16, 204–210 (2020). https://doi.org/10.1089/chi.2019.0280
A. Sivan, L. Corrales, N. Hubert, J.B. Williams, K. Aquino-Michaels, Z.M. Early, F.W. Benyamin, Y.M. Lei, B. Jabri, M.L. Alegre, E.B. Chang, T.F. Gajewski, Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084–1089 (2015). https://doi.org/10.1126/science.aac4255
K. Skonieczna-Żydecka, K. Jakubczyk, D. Maciejewska-Markiewicz, K. Janda, K. Kaźmierczak-Siedlecka, M. Kaczmarczyk, I. Łoniewski, W. Marlicz, Gut biofactory-neurocompetent metabolites within the gastrointestinal tract. A scoping review. Nutrients 12(11), 3369 (2020). https://doi.org/10.3390/nu12113369
K.S. Smirnov, T.V. Maier, A. Walker, S.S. Heinzmann, S. Forcisi, I. Martinez, J. Walter, P. Schmitt-Kopplin, Challenges of metabolomics in human gut microbiota research. Int. J. Med. Microbiol. 306, 266–279 (2016). https://doi.org/10.1016/j.ijmm.2016.03.006
B. Stecher, The roles of inflammation, nutrient availability and the commensal microbiota in enteric pathogen infection. Microbiol. Spectr. 3, 297–320 (2015). https://doi.org/10.1128/microbiolspec.MBP-0008-2014
Y. Su, D. Chen, D. Yuan, C. Lausted, J. Choi, C.L. Dai, V. Voillet, V.R. Duvvuri, K. Scherler, P. Troisch, P. Baloni, G. Qin, B. Smith, S.A. Kornilov, C. Rostomily, A. Xu, J. Li, S. Dong, A. Rothchild, J. Zhou, K. Murray, R. Edmark, S. Hong, J.E. Heath, J. Earls, R. Zhang, J. Xie, S. Li, R. Roper, L. Jones, Y. Zhou, L. Rowen, R. Liu, S. Mackay, D.S. O’Mahony, C.R. Dale, J.A. Wallick, H.A. Algren, M.A. Zager, ISB-Swedish COVID19 Biobanking Unit, W. Wei, N.D. Price, S. Huang, N. Subramanian, K. Wang, A.T. Magis, J.J. Hadlock, L. Hood, A. Aderem, J.A. Bluestone, L.L. Lanier, P.D. Greenberg, R. Gottardo, M.M. Davis, J.D. Goldman, J.R. Heath, Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183(6), 1479–1495.e20 (2020). https://doi.org/10.1016/j.cell.2020.10.037
A.C. Tadrowski, M.R. Evans, B. Waclaw, Phenotypic switching can speed up microbial evolution. Sci. Rep. 8, 8941 (2018). https://doi.org/10.1038/s41598-018-27095-9
H. Tamaki, H. Nakase, S. Inoue, C. Kawanami, T. Itani, M. Ohana, T. Kusaka, S. Uose, H. Hisatsune, M. Tojo, T. Noda, S. Arasawa, M. Izuta, A. Kubo, C. Ogawa, T. Matsunaka, M. Shibatouge, Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Dig. Endosc. 28(1), 67–74 (2016). https://doi.org/10.1111/den.12553
O.R. Tamtaji, M. Taghizadeh, R. Daneshvar Kakhaki, E. Kouchaki, F. Bahmani, S. Borzabadi, S. Oryan, A. Mafi, Z. Asemi, Clinical and metabolic response to probiotic administration in people with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 38(3), 1031–1035 (2019). https://doi.org/10.1016/j.clnu.2018.05.018
G. Tang, L. Zhang, Update on strategies of probiotics for the prevention and treatment of colorectal cancer. Nutr. Cancer 74(1), 27–38 (2022). https://doi.org/10.1080/01635581.2020.1865420
T. Thomas, J. Gilbert, F. Meyer, Metagenomics – A guide from sampling to data analysis. Microb. Inform. Exp. 9, 3 (2012). https://doi.org/10.1186/2042-5783-2-3
L. Tipton, J.L. Darcy, N.A. Hynson, A developing symbiosis: Enabling cross-talk between ecologists and microbiome scientists. Front. Microbiol. 10 (2019). https://doi.org/10.3389/FMICB.2019.00292
A.S. Torson, Y.W. Dong, B.J. Sinclair, Help, there are “omics” in my comparative physiology! J. Exp. Biol. 223, jeb191262 (2020). https://doi.org/10.1242/jeb.191262
S. Uroz, P.E. Courty, P. Oger, Plant symbionts are engineers of the plant-associated microbiome. Trends Plant Sci. 24, 905–916 (2019). https://doi.org/10.1016/j.tplants.2019.06.008
L. Valdés-Varela, M. Gueimonde, P. Ruas-Madiedo, Probiotics for prevention and treatment of Clostridium difficile infection. Adv. Exp. Med. Biol. 1050, 161–176 (2018). https://doi.org/10.1007/978-3-319-72799-8_10
A.M. Vargason, A.C. Anselmo, Evaluation of surface modified live biotherapeutic products for oral delivery. ACS Biomater Sci. Eng. (2020). https://doi.org/10.1021/acsbiomaterials.0c01405
N.C. Verberkmoes, A.L. Russell, M. Shah, A. Godzik, M. Rosenquist, J. Halfvarson, M.G. Lefsrud, J. Apajalahti, C. Tysk, R.L. Hettich, J.K. Jansson, Shotgun metaproteomics of the human distal gut microbiota. ISME J. 3, 179–189 (2009). https://doi.org/10.1038/ismej.2008.108
E.F. Verdu, P. Bercik, G.E. Bergonzelli, X.-X. Huang, P. Blennerhasset, F. Rochat, M. Fiaux, R. Mansourian, I. Corthésy-Theulaz, S.M. Collins, Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 127, 826–837 (2004). https://doi.org/10.1053/j.gastro.2004.06.007
E.F. Verdu, P. Bercik, M. Verma-Gandhu, X.-X. Huang, P. Blennerhassett, W. Jackson, Y. Mao, L. Wang, F. Rochat, S.M. Collins, Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55, 182–190 (2006). https://doi.org/10.1136/gut.2005.066100
S. Verheijden, G.E. Boeckxstaens, Neuroimmune interaction and the regulation of intestinal immune homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 314, G75–G80 (2018). https://doi.org/10.1152/ajpgi.00425.2016
A. Vrieze, F. Holleman, E.G. Zoetendal, W.M. De Vos, J.B.L. Hoekstra, M. Nieuwdorp, The environment within: How gut microbiota may influence metabolism and body composition. Diabetologia 53, 606–613 (2010). https://doi.org/10.1007/s00125-010-1662-7
A.W. Walker, S.H. Duncan, P. Louis, H.J. Flint, Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 22, 267–274 (2014). https://doi.org/10.1016/j.tim.2014.03.001
M. Wang, M. Li, S. Wu, C.B. Lebrilla, R.S. Chapkin, I. Ivanov, S.M. Donovan, Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. J. Pediatr. Gastroenterol. Nutr. 60, 825–833 (2015). https://doi.org/10.1097/MPG.0000000000000752
D.Z. Wang, L.F. Kong, Y.Y. Li, Z.X. Xie, Environmental microbial community proteomics: Status, challenges and perspectives. Int. J. Mol. Sci. 17, 1275 (2016). https://doi.org/10.3390/ijms17081275
N. Wang, F. Zhu, L. Chen, K. Chen, Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications. Life Sci. 212, 194–202 (2018). https://doi.org/10.1016/j.lfs.2018.09.035
Z. Wang, Z. Lai, X. Zhang, P. Huang, J. Xie, Q. Jiang, Q. Zhang, K.F. Chung, Altered gut microbiome compositions are associated with the severity of asthma. J. Thorac. Dis. 13, 4322–4338 (2021). https://doi.org/10.21037/jtd-20-2189
J.C. Wells, A.L. Sawaya, R. Wibaek, M. Mwangome, M.S. Poullas, C.S. Yajnik, A. Demaio, The double burden of malnutrition: Aetiological pathways and consequences for health. Lancet 395(10217), 75–88 (2020). https://doi.org/10.1016/S0140-6736(19)32472-9
World Health Organization, Global Nutrition Targets 2025 Breastfeeding Policy Brief (2014). https://apps.who.int/iris/handle/10665/149022. Accessed 29 Jan 2022
T. Yang, H. Li, A.C. Oliveira, R. Goel, E.M. Richards, C.J. Pepine, M.K. Raizada, Transcriptomic signature of gut microbiome-contacting cells in colon of spontaneously hypertensive rats. Physiol. Genomics 52, 121–132 (2020). https://doi.org/10.1152/physiolgenomics.00087.2019
Z.T. Yu, C. Chen, D.E. Kling, B. Liu, J.M. McCoy, M. Merighi, M. Heidtman, D.S. Newburg, The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology 23, 169–177 (2013). https://doi.org/10.1093/glycob/cws138
R. Yu, F. Zuo, H. Ma, S. Chen, Exopolysaccharide-producing bifidobacterium adolescentis strains with similar adhesion property induce differential regulation of inflammatory immune response in Treg/Th17 axis of DSS-colitis mice. Nutrients 11, 1–20 (2019). https://doi.org/10.3390/nu11040782
L. Zhang, H. Yi, Potential antitumor and anti-inflammatory activities of an extracellular polymeric substance (EPS) from Bacillus subtilis isolated from a housefly. Sci. Rep. 12, 1–10 (2022). https://doi.org/10.1038/s41598-022-05143-9
X. Zhang, S.A. Deeke, Z. Ning, A.E. Starr, J. Butcher, J. Li, J. Mayne, K. Cheng, B. Liao, L. Li, R. Singleton, D. Mack, A. Stintzi, D. Figeys, Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat. Commun. 9, 2873–2887 (2018). https://doi.org/10.1038/s41467-018-05357-4
M.A.C. Zijlmans, K. Korpela, J.M. Riksen-Walraven, W.M. de Vos, C. Weerth, Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology 53, 233–245 (2015). https://doi.org/10.1016/j.psyneuen.2015.01.006
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Freitas, P.N.N., Silva, C.R., Constantin, P.P., Pileggi, S.A.V., Vicari, M.R., Pileggi, M. (2023). Fixing the Damage: The Evolution of Probiotics from Fermented Food to Biotherapeutic Products. In: Oncel, S.S. (eds) A Sustainable Green Future. Springer, Cham. https://doi.org/10.1007/978-3-031-24942-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-24942-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-24941-9
Online ISBN: 978-3-031-24942-6
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)